Hip Inflammation MRI Scoring System (HIMRISS) to predict response to hyaluronic acid injection in hip osteoarthritis-Reference-Cited by-同舟云学术

Hip Inflammation MRI Scoring System (HIMRISS) to predict response to hyaluronic acid injection in hip osteoarthritis

Published:2018-07 Issue:4 Volume:85 Page:475-480
ISSN:1297-319X
Container-title:Joint Bone Spine
language:en
Short-container-title:Joint Bone Spine

Author:

Deseyne Nicolas,Conrozier Thierry,Lellouche Henri,Maillet Bernard,Weber Ulrich,Jaremko Jacob L.,Paschke Joel,Epstein Jonathan,Maksymowych Walter P.,Loeuille Damien

Publisher

Elsevier BV

Subject

Rheumatology

Reference37 articles.

1. Primary osteoarthritis of the hip: etiology and epidemiology;Hoaglund;J Am Acad Orthop Surg,2001

2. An update on the epidemiology of knee and hip osteoarthritis with a view to prevention;Felson;Arthritis Rheum,1998

3. Total joint replacement in osteoarthritis;Katz;Best Pract Res Clin Rheumatol,2006

4. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data;Kotlarz;Arthritis Rheum,2009

5. Hip osteoarthritis and the risk of all-cause and disease-specific mortality in older women: a population-based cohort study;Barbour;Arthritis Rheumatol,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local injection therapy with hyaluronic acid preparations: in focus of rheumatologists and orthopedic traumatologists;Modern Rheumatology Journal;2024-06-15

2. Local injection therapy in the complex treatment of musculoskeletal disorders: principles of application, evidence base, safety;Modern Rheumatology Journal;2023-08-18

3. Imaging of Osteoarthritis of the Hip;Radiologic Clinics of North America;2022-07

4. Improved-Mask R-CNN: Towards an accurate generic MSK MRI instance segmentation platform (data from the Osteoarthritis Initiative);Computerized Medical Imaging and Graphics;2022-04

5. Open-Label Pilot Study of a Single Intra-Articular Injection of Mannitol-Modified Cross-Linked Hyaluronic Acid (HANOX-M-XL) for the Treatment of the First Metatarsophalangeal Osteoarthritis (Hallux Rigidus): The REPAR Trial;Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders;2022-01